SUPER SPRAY

SUPER SPRAY: An Antibiotic Spray for Horses and Camels

SUPER SPRAY is a veterinary product containing oxytetracycline, a broad-spectrum antibiotic used to treat various bacterial infections in racing horses and camels. It is available as a topical spray, making it easy to apply to affected areas.

Key Benefits:

• Broad-spectrum antibacterial activity: Oxytetracycline is effective against a wide range of gram-positive and gram-negative bacteria commonly causing infections in horses and camels.
• Convenient topical application: The spray formulation of SUPER SPRAY allows for easy and targeted application to wounds, surgical sites, and hoof infections, ensuring direct contact with the affected area.
• Potential to reduce wound healing time: By combating bacterial infections, SUPER SPRAY may help promote faster wound healing and reduce the risk of complications.

Veterinary Uses:

• Treatment of bacterial infections: SUPER SPRAY is primarily used to treat various bacterial infections in horses and camels, including:
  • Wound infections: Abrasions, lacerations, and surgical wounds.
  • Ocular infections: Conjunctivitis and keratitis.
  • Hoof infections: Thrush, white line disease, and seedy toe.
  • Other skin infections: Dermatitis and cellulitis.
• Prophylaxis: In some cases, SUPER SPRAY may be used prophylactically to prevent bacterial infections following surgery or other procedures.

Important Considerations:

• Do not use SUPER SPRAY on animals with a known hypersensitivity to oxytetracycline.
• This product may cause local irritation at the application site. Discontinue use and consult your veterinarian if you notice any signs of adverse reactions.
• Avoid contact with the eyes, mouth, and other mucous membranes.
• Consult your veterinarian before using SUPER SPRAY on pregnant or lactating animals.
• Prolonged use of SUPER SPRAY can lead to the development of antibiotic resistance.

Please refer to the product label or consult with your veterinarian for specific dosing recommendations.

Chlonetracycline (HCI) 17.8 mg; Patent blue 0.7 mg.